Funding Opportunities

HVTN Research and Mentorship Program (RAMP) Scholar Program
Funding Opportunity Number: PA-19-096
Closing Date: January 6, 2020

Transgender People: Immunity, Prevention, and Treatment (R21 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-20-054
Posting Date: November 12, 2019
Closing Date: May 11, 2020

Assessing the Effects of Cannabinoids on HIV-Induced Inflammation (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-20-022
Posting Date: November 7, 2019
Closing Date: March 11, 2020

Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-20-039
Posting Date: October 25, 2019
Expiration Date: September 8, 2022

Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Optional)
Funding Opportunity Number: PAR-20-036
Posting Date: October 23, 2019
Expiration Date: September 8, 2022

HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)
Funding Opportunity Number: PAR-20-030
Posting Date: October 18, 2019
Closing Date: December 15, 2019; December 3, 2020

Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-20-029
Posting Date: October 10, 2019
Closing Date: January 7, 2020; January 7, 2021; January 7, 2022

Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01, Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-19-357
Posting Date: September 3, 2019
Expiration Date: January 11, 2022

Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21, Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-19-364
Posting Date: September 3, 2019
Expiration Date: January 11, 2022

Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional)
Funding Opportunity Number: PAR-18-732
Posting Date: July 31, 2019
Closing Date: November 12, 2020 by 5:00 PM

Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional)
Funding Opportunity Number: PAR-18-732
Posting Date: November 1, 2020
Closing Date: Standard dates apply, by 5:00 PM local time of applicant organization.

Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed)
Funding Opportunity Number: PA-19-096
Posting Date: January 08, 2022
Closing Date: Standard dates apply, by 5:00 PM local time of applicant organization.

Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAS-19-097
Posting Date: January 08 , 2022
Closing Date: Standard dates apply, by 5:00 PM local time of applicant organization.

Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21)
Funding Opportunity Number: PA-16-425
Posting Date: September 7, 2016
Closing Date: Standard AIDS dates apply, by 5:00 PM local time of applicant organization.

For information about additional funding opportunities please click the relevant link below

For National Institute of Health (NIH):

  • For NIAID click here
  • For NIDA click here
  • For NHLBI click here
  • For NIMH click here

For Centers for Disease Control and Prevention (CDC) Click Here

For Health Resources & Services Administration (HRSA) Click Here